Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of ICON Plc and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

Berkshire, Helmerich & Payne on the list Continue reading...

Centene makes the list Continue reading...

This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...

Great investments find ways to create quality that sometimes can't be measured by numbers alone Continue reading...

ICON plc to Present at UBS Virtual Global Healthcare Conference

ICON signs new Service Agreement with Pfizer

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Icon PLC (ICLR) delivered earnings and revenue surprises of -1.16% and 0.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]

ICON plc, (NASDAQ: ICLR) a global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, has won awards across multiple categories in the annual CRO Leadership Awards.

ICON plc to Present at Jefferies Virtual Healthcare Conference

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.00% and -1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Those holding ICON (NASDAQ:ICLR) shares must be pleased that the share price has rebounded 38% in the last thirty...

ICON Reports First Quarter 2020 Results

Full Year 2019 ICON PLC Earnings Call

The annual results for ICON Public Limited Company (NASDAQ:ICLR) were released last week, making it a good time to...

Q1 2020 ICON PLC Earnings Call

ICON plc, (NASDAQ: ICLR) a leading global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Kristen K. Buck has been appointed Chief Medical Officer.

ICON plc to Present at Barclays Global Healthcare Conference 2020